Opinion

Published on 28 May 2021

Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article

in Renal Pharmacology

Natalia Stepanova

Frontiers in Pharmacology

doi 10.3389/fphar.2021.692429

7,245 views
12 citations

Original Research

Published on 28 May 2021

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition

in Renal Pharmacology

Qing Kuang
Sheng Wu
Ning Xue
Xiaoyan Wang
Xiaoqianq Ding
Yi Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.667282

3,763 views
7 citations

Mini Review

Published on 26 May 2021

Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease

in Renal Pharmacology

Qing Li
Changying Xing
Yanggang Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.632388

5,989 views
6 citations

Original Research

Published on 20 May 2021

Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection

in Renal Pharmacology

Hironari Hanaoka
Jun Kikuchi
Yuko Kaneko
Noriyasu Seki
Hideto Tsujimoto
Kenji Chiba
Tsutomu Takeuchi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.616719

4,069 views
4 citations

Original Research

Published on 13 May 2021

Ameliorative Effects of Osthole on Experimental Renal Fibrosis in vivo and in vitro by Inhibiting IL-11/ERK1/2 Signaling

in Renal Pharmacology

Fan Wu
Yan Zhao
Qingqing Shao
Ke Fang
Ruolan Dong
Shujun Jiang
Fuer Lu
Jinlong Luo
Guang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.646331

4,262 views
9 citations

Original Research

Published on 13 May 2021

Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy

in Renal Pharmacology

Nanwen Zhang
Qingmei Zheng
Yaduan Wang
Juan Lin
He Wang
Rui Liu
Mengru Yan
Xiaofeng Chen
Juhua Yang
Xiaole Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.681424

3,453 views
13 citations

Original Research

Published on 11 May 2021

Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats

in Renal Pharmacology

Yenan Mo
Huang Sun
Lei Zhang
Wenjia Geng
Lixin Wang
Chuan Zou
Yuchi Wu
Chunlan Ji
Xusheng Liu
Zhaoyu Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.657827

6,129 views
18 citations

Original Research

Published on 10 May 2021

Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy

in Renal Pharmacology

Hailan Cui
Frank Qiang Fu
Baoli Liu
Wei Jing Liu
Yu Ning Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.675406

4,699 views
5 citations

Original Research

Published on 07 May 2021

Ibudilast Attenuates Folic Acid–Induced Acute Kidney Injury by Blocking Pyroptosis Through TLR4-Mediated NF-κB and MAPK Signaling Pathways

in Renal Pharmacology

Xue Li
Yu Zou
Yuan-Yuan Fu
Jia Xing
Kai-Yue Wang
Peng-Zhi Wan
Mo Wang
Xiao-Yue Zhai

Frontiers in Pharmacology

doi 10.3389/fphar.2021.650283

8,580 views
35 citations

Systematic Review

Published on 06 May 2021

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis

in Renal Pharmacology

Mingming Zhao
Rumeng Wang
Yi Yu
Meiying Chang
Sijia Ma
Hanwen Zhang
Hua Qu
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.638611

10,880 views
5 citations

Original Research

Published on 03 May 2021

Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia

in Renal Pharmacology

Amaresh K. Ranjan
Zhong Zhang
Seema Briyal
Anil Gulati

Frontiers in Pharmacology

doi 10.3389/fphar.2021.616253

3,886 views
10 citations

Original Research

Published on 29 Apr 2021

lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis

in Renal Pharmacology

Haozi Huang
Guowei Zhang
Zhenying Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2021.647650

5,646 views
36 citations

Systematic Review

Published on 29 Apr 2021

Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis

in Renal Pharmacology

Wenlin Liu
Lili Li
Xuemei Zhang
Haonan Dong
Miaomiao Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.643128

3,839 views
1 citation

Review

Published on 29 Apr 2021

Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials

in Renal Pharmacology

Rossana Franzin
Alessandra Stasi
Elena Ranieri
Giuseppe Stefano Netti
Vincenzo Cantaluppi
Loreto Gesualdo
Giovanni Stallone
Giuseppe Castellano

Frontiers in Pharmacology

doi 10.3389/fphar.2021.630419

10,014 views
25 citations

Original Research

Published on 29 Apr 2021

Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling Time

in Renal Pharmacology

Sarah Baklouti
Didier Concordet
Vitaliano Borromeo
Paola Pocar
Paola Scarpa
Petra Cagnardi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.634404

2,429 views
5 citations

Review

Published on 28 Apr 2021

PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy

in Renal Pharmacology

Ruizhen Huang
Chiyu Zhang
Xing Wang
Honglin Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.600618

7,418 views
19 citations

Navigation group

Articles

Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition

Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease

Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection

Ameliorative Effects of Osthole on Experimental Renal Fibrosis in vivo and in vitro by Inhibiting IL-11/ERK1/2 Signaling

Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy

Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats

Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy

Ibudilast Attenuates Folic Acid–Induced Acute Kidney Injury by Blocking Pyroptosis Through TLR4-Mediated NF-κB and MAPK Signaling Pathways

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis

Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia

lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis

Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis

Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials

Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling Time

PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy